Abstract
The National Institute on Drug Abuse (NIDA) is looking at ways to increase access to methadone, which, for patients with opioid use disorder, is currently available only through opioid treatment programs (OTPs), ADAW has learned. NIDA wants to look at more than what would be allowed by regulation: primary care, pharmacies, mobile vans and more. This would be most likely done through NIDA's Clinical Trials Network. There are many treatment advocates who think less‐regulated systems would be valuable for long‐term stable patients, but not for new patients. It is expected that patients will play a role in whatever is developed — but this is not guaranteed, not by a long shot. Confidentiality is still a prized ingredient of going to an OTP.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
